Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

This study has been completed.
Sponsor:
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00423839
First received: January 17, 2007
Last updated: NA
Last verified: December 2006
History: No changes posted